AR008234A1 - Derivados de benzamidas, procedimiento para su preparacion, composiciones farmaceuticas y su uso para la preparacion de un medicamento - Google Patents
Derivados de benzamidas, procedimiento para su preparacion, composiciones farmaceuticas y su uso para la preparacion de un medicamentoInfo
- Publication number
- AR008234A1 AR008234A1 ARP970102610A ARP970102610A AR008234A1 AR 008234 A1 AR008234 A1 AR 008234A1 AR P970102610 A ARP970102610 A AR P970102610A AR P970102610 A ARP970102610 A AR P970102610A AR 008234 A1 AR008234 A1 AR 008234A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- preparation
- hydrogen
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Derivados de benzamidas caracterizados porque comprenden un compuesto de fórmula I o una de sus sales farmaceuticamente aceptables en la que n y p,independientemente son números enteros de 1 a 4 y (n+p)es alquil (C1-C6)-O-, R2 es hidrógeno,halóge no, CN, N3trifluormetildiazirinilo, CF3, CF3O-, CF3CO-,alquilo (C1-C6) cicloalquilo (C3-C6, cicloalquil (C3-C6)-alquilo (C1-C4) cicloalquil (C3-C6)-alquil (C1-C4)-CO--, fenilo, fenoxi, benciloxi, benzoílo,fenil-alquilo(C1-C4) alquil(C1-C6)-s -,alquil(C1-C6)-SO2-, alquil (C1-C4)-NHSO2-; R3 es hidrógeno, halógeno, NO2, CN N3, trifluorometildiazirinilo, alquil(C1-C6)-O-, alquil (C1-C6)-S-,alquilo (C1-C6), cicloalquilo (C3-C6), cicloalquil (C3-C6)-S-alquilo (C1-C4),alquenilo (C1 -C6), alquinilo (C1-C6),CF3CO- alquil (C1-C6), cicloalquil (C3-C6)-CO-, cicloalquil (C3-C6)-alquil (C1-C4)-CO-fenilo, fenoxi, benciloxi, benzoílo, fenil-alquilo (C1-C4) o -NR5R6,en el que R5 es hidrógeno o alquilo (C1-C4), y R6 eshidrógeno, alq uilo (C1-C4), y R6 es hidrógeno, alquilo (C1-C4), -CHO, -CO2- alquilo (C1-C4), o -co-alquilo(C1-C4; R4 es hidrógeno, alquilo (C1-C6), alquenilo (C1-C6) o alquinilo (C1-C6) pero excluyendo el compuesto 2, 4, 5-trimetoxi-N-(2-metil-1,2, 3, 4-tetrahidr oisoquino) in-5-il)benzamida. Se refiere tambien al uso de estos compuestos como anticonvulsivos en ciertos estados médicos y a losprocedimientos para su preparación y a una composición farmacéutica.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9612608.1A GB9612608D0 (en) | 1996-06-17 | 1996-06-17 | Novel compounds |
| GBGB9615352.3A GB9615352D0 (en) | 1996-07-22 | 1996-07-22 | Novel compounds |
| GBGB9711013.4A GB9711013D0 (en) | 1997-05-28 | 1997-05-28 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008234A1 true AR008234A1 (es) | 1999-12-29 |
Family
ID=27268330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102610A AR008234A1 (es) | 1996-06-17 | 1997-06-13 | Derivados de benzamidas, procedimiento para su preparacion, composiciones farmaceuticas y su uso para la preparacion de un medicamento |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6110934A (es) |
| EP (1) | EP0906283A1 (es) |
| AR (1) | AR008234A1 (es) |
| AU (1) | AU729124B2 (es) |
| BR (1) | BR9709906A (es) |
| CA (1) | CA2258238A1 (es) |
| CZ (1) | CZ416498A3 (es) |
| HU (1) | HUP9902166A3 (es) |
| IL (1) | IL127068A0 (es) |
| NO (1) | NO985891D0 (es) |
| NZ (1) | NZ332757A (es) |
| PL (1) | PL330465A1 (es) |
| TR (1) | TR199802745T2 (es) |
| WO (1) | WO1997048683A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ2446A1 (fr) * | 1997-03-18 | 2003-01-11 | Smithkline Beecham Plc | Nouveaux composés |
| US20010016657A1 (en) | 1997-03-18 | 2001-08-23 | Smithkline Beecham P.L.C. | Substituted isoquinoline derivatives and their use as anticonvulsants |
| GB9726695D0 (en) * | 1997-12-17 | 1998-02-18 | Smithkline Beecham Plc | Novel compounds |
| BR9809047A (pt) * | 1997-03-18 | 2000-08-01 | Smithkline Beecham Plc | Derivados de isoquinolina substituìda e o uso dos mesmos como anticonvulsivantes |
| GB9812683D0 (en) | 1998-06-12 | 1998-08-12 | Smithkline Beecham Plc | Novel compounds |
| GB9816984D0 (en) * | 1998-08-05 | 1998-09-30 | Smithkline Beecham Plc | Novel compounds |
| GB9817424D0 (en) | 1998-08-11 | 1998-10-07 | Smithkline Beecham Plc | Novel compounds |
| GB9915589D0 (en) | 1999-07-02 | 1999-09-01 | Smithkline Beecham Plc | Novel compounds |
| EP2033953A1 (en) * | 2002-02-15 | 2009-03-11 | Glaxo Group Limited | Vanilloid receptor modulators |
| GB0210762D0 (en) * | 2002-05-10 | 2002-06-19 | Glaxo Group Ltd | Compounds |
| BRPI0411083A (pt) | 2003-06-12 | 2006-07-25 | Astellas Pharma Inc | derivado de benzamida ou sais do mesmo |
| US20050165028A1 (en) * | 2004-01-23 | 2005-07-28 | Norman Mark H. | Vanilloid receptor ligands and their use in treatments |
| ES2596532T3 (es) * | 2006-03-16 | 2017-01-10 | Second Genome, Inc. | Compuestos de bicicloheteroarilo como moduladores de P2X7 y usos de los mismos |
| DK2046787T3 (da) | 2006-08-01 | 2011-07-18 | Glaxo Group Ltd | Pyrazolo[3,4-B]pyridin-forbindelser, og deres anvendelse som PDE4-inhibitorer |
| CN115397412A (zh) | 2020-04-17 | 2022-11-25 | 伊赛恩特制药公司 | Mas相关g蛋白受体x4的调节剂及相关产物和方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE634851A (es) * | 1963-05-15 | 1900-01-01 | ||
| US4022900A (en) * | 1970-09-09 | 1977-05-10 | Marion Laboratories, Inc. | Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents |
-
1997
- 1997-06-13 TR TR1998/02745T patent/TR199802745T2/xx unknown
- 1997-06-13 WO PCT/EP1997/003131 patent/WO1997048683A1/en not_active Application Discontinuation
- 1997-06-13 CZ CZ984164A patent/CZ416498A3/cs unknown
- 1997-06-13 EP EP97928214A patent/EP0906283A1/en not_active Withdrawn
- 1997-06-13 US US09/202,524 patent/US6110934A/en not_active Expired - Fee Related
- 1997-06-13 PL PL97330465A patent/PL330465A1/xx unknown
- 1997-06-13 AU AU32595/97A patent/AU729124B2/en not_active Ceased
- 1997-06-13 IL IL12706897A patent/IL127068A0/xx unknown
- 1997-06-13 CA CA002258238A patent/CA2258238A1/en not_active Abandoned
- 1997-06-13 HU HU9902166A patent/HUP9902166A3/hu unknown
- 1997-06-13 NZ NZ332757A patent/NZ332757A/xx unknown
- 1997-06-13 BR BR9709906A patent/BR9709906A/pt unknown
- 1997-06-13 AR ARP970102610A patent/AR008234A1/es not_active Application Discontinuation
-
1998
- 1998-12-16 NO NO985891A patent/NO985891D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO985891L (no) | 1998-12-16 |
| US6110934A (en) | 2000-08-29 |
| HUP9902166A2 (hu) | 1999-10-28 |
| WO1997048683A1 (en) | 1997-12-24 |
| BR9709906A (pt) | 1999-08-10 |
| HUP9902166A3 (en) | 2001-01-29 |
| TR199802745T2 (xx) | 1999-04-21 |
| CA2258238A1 (en) | 1997-12-24 |
| NO985891D0 (no) | 1998-12-16 |
| CZ416498A3 (cs) | 1999-06-16 |
| IL127068A0 (en) | 1999-09-22 |
| PL330465A1 (en) | 1999-05-24 |
| NZ332757A (en) | 1999-06-29 |
| AU729124B2 (en) | 2001-01-25 |
| AU3259597A (en) | 1998-01-07 |
| EP0906283A1 (en) | 1999-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008234A1 (es) | Derivados de benzamidas, procedimiento para su preparacion, composiciones farmaceuticas y su uso para la preparacion de un medicamento | |
| AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
| UY29825A1 (es) | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones | |
| AR008377A1 (es) | Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto | |
| PH23607A (en) | Amide derivatives and pharmaceutical composition containing said compounds | |
| NO963053L (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
| ES2081187T3 (es) | Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| HUP0204147A2 (hu) | [(RR,SS)-3-(2-dimetilaminoetil-1-hidroxiciklohexil)fenil]-2-hidroxibenzoátból származtatott új észterek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| SV1997000026A (es) | Composiciones farmaceuticas para el tratamiento de la rinitis | |
| ES2038172T3 (es) | Procedimiento para preparar carboxamidas heterociclicas. | |
| AR009572A1 (es) | Derivados de 3,4,5,6,7,8-hexahidro pirido (4',3':4,5) tieno (2,3-d) pirimidina sustituidos en posicion 3 y su uso | |
| UY23395A1 (es) | Derivados de amidinofenilalanina, procedimiento para su fabricacion, su empleo y agente que los contienen | |
| BRPI9509819B8 (pt) | benzamida enterocinética e composição farmacêutica compreendendo a mesma | |
| AR007012A1 (es) | Compuestos de 2-fenil-3-benzoil-benzotiofenos, composiciones farmaceuticas que los contienen y el uso de dichos compuestos para el tratamiento del sindrome postmenopausico, inhibicion del cancer estrogenodependiente, entre otras afecciones patologicas | |
| ES2135695T3 (es) | Derivados de aminoacidos y su uso como inhibidores de la fosfolipasa a2. | |
| PE45195A1 (es) | Derivado de aminoacido, procedimiento para su preparacion y composicion farmaceutica que lo contiene | |
| DK0516350T3 (da) | 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister | |
| BR9912816A (pt) | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos | |
| AR009374A1 (es) | Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos. | |
| AR002264A1 (es) | 6-[triazolil[3(trifluormetil)fenil]metil]-2-quinolinonas y quinolintionas, un procedimiento para su preparacion, una composicion que las comprende, unprocedimiento para su preparacion, el uso de las mismas para la preparacion de un medicamento y un intermediario. | |
| KR910002775A (ko) | 방향족 카복실산 아미드 | |
| ATE63563T1 (de) | Synergistin-derivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ES2165410T3 (es) | Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| AR016212A1 (es) | Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas | |
| AR037427A1 (es) | Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimiento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |